Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life-Course.

Allergy Child Epidemiology Genetics Risk factor

Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
09 Jul 2024
Historique:
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 9 7 2024
Statut: aheadofprint

Résumé

Asthma is a descriptive label for an obstructive, inflammatory disease in the lower airways manifesting with symptoms including breathlessness, cough, difficulty in breathing and wheezing. From a clinician's point of view, asthma symptoms can commence at any age although most asthma patients - regardless of their age of onset - seem to have had some form of airway problems during childhood. Asthma inception and related pathophysiologic processes are therefore very likely to occur early in life, further evidenced by recent lung physiologic and mechanistic research. Herein, we present state-of-the-art updates on the role of genetics and epigenetics, early viral and bacterial infections, immune response and pathophysiology as well as lifestyle and environmental exposures in asthma across the life-course. We conclude early environmental insults in genetically vulnerable individuals to induce an abnormal, pre-asthmatic airway response as key events in asthma inception and highlight disease heterogeneity - across ages - and the potential shortness of treating all patients with asthma using the same treatments. Although there are no interventions that, at present, can modify long-term outcomes, a precision-medicine approach should be implemented to optimize treatment and tailor follow-up for all patients with asthma.

Identifiants

pubmed: 38981012
doi: 10.1164/rccm.202312-2249SO
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Erik Melén (E)

Karolinska Institutet Department of Clinical Science and Education Sodersjukhuset, Karolinska Institutet, Stockholm, Sweden; erik.melen@ki.se.

Heather J Zar (HJ)

University of Capetown, Pediatrics & Child Health, Cape Town, South Africa.
MRC Unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.

Valerie Siroux (V)

INSERM, IAB. Team of Environmental Epidemiology applied to Reproduction and Respiratory Health. , Grenoble, F-38000, France.
Univ. Grenoble Alpes. IAB. , Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Grenoble, F-38000, France.
CHU de Grenoble, IAB. Team of Environmental Epidemiology applied to Reproduction and Respiratory Health., Grenoble, F-38000, France.

Dominic Shaw (D)

University of Nottingham, Respiratory Research Unit, Nottingham, United Kingdom of Great Britain and Northern Ireland.

Sejal Saglani (S)

Royal Brompton Hospital, Respiratory Paediatrics, London, United Kingdom of Great Britain and Northern Ireland.

Gerard H Koppelman (GH)

University of Groningen, University Medical Center Groningen, Department of Pulmonology and Pediatric Allergy, Beatrix Children's Hospital, Groningen, Netherlands.
University of Groningen, University Medical Center Groningen, GRIAC research institute, Groningen, Netherlands.

Tina Hartert (T)

Vanderbilt University Medical Center, Medicine, Nashville, Tennessee, United States.

James E Gern (JE)

University of Wisconsin-Madison, Pediatrics, Madison, Wisconsin, United States.

Benjamin Gaston (B)

Case Western Reserve University, Cleveland, Ohio, United States.

Andrew Bush (A)

Imperial College London, London, United Kingdom of Great Britain and Northern Ireland.

Joe Zein (J)

Mayo Clinic, Phoenix, Arizona, United States.

Classifications MeSH